Acceleron Pharma to Present at Upcoming Investor Conferences in June

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced it will participate in the following upcoming investor conferences.

Event:				Jefferies 2015 Global Healthcare Conference
Date / Time:				Monday, June 1, 2015 at 4:00 PM (EDT)
Location:				New York, N.Y.
Event:				JMP Securities Life Sciences Conference
Date / Time:				Tuesday, June 23, 2015 at 2:30 PM (EDT)
Location:				The St. Regis, New York, N.Y.

Live audio webcasts will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (www.acceleronpharma.com). A replay of the webcasts will also be available from Acceleron’s website.

About Acceleron

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta (TGF-beta) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical therapeutic candidates with novel mechanisms of action. These therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.

For more information, please visit www.acceleronpharma.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005350/en/

Acceleron Pharma Inc.
Kevin F. McLaughlin, 617-649-9204
Senior Vice President and Chief Financial Officer
or
Media:
Suda Communications LLC
Maureen L. Suda, 585-387-9248

Source: Acceleron Pharma Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SonicStrategy Reports Q2 2026 Staking Revenue and Reduced Monthly Burn
• Mako Mining Files Technical Report for Moss Mine Mineral Resource and Reserve Estimates and Life of Mine Plan
• CoVolt Power Announces Public Filing of Registration Statement for Proposed Initial Public Offering